Low yield of endoscopy in patients with persistent dyspepsia taking proton pump inhibitors

Gastrointestinal Endoscopy

Volumn 58, Issue 1, 2003, Pages 9-13

  Smith, Terrence ^a   Verzola, Edwardo ^a   Mertz, Howard ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; GASTROINTESTINAL AGENT; PROTON PUMP;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DYSPEPSIA; ENDOSCOPY; ESOPHAGITIS; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; PRIORITY JOURNAL; TREATMENT OUTCOME; ULCER; AGED; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; DRUG ANTAGONISM; DRUG EFFECT; FOLLOW UP; GASTROSCOPY; HELICOBACTER INFECTION; HOSPITALIZATION; ISOLATION AND PURIFICATION; MIDDLE AGED; PAIN ASSESSMENT; PATHOLOGY; PROBABILITY; QUESTIONNAIRE; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; STOMACH MUCOSA;

ADULT; AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DYSPEPSIA; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; GASTROINTESTINAL AGENTS; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PROBABILITY; PROTON PUMPS; QUESTIONNAIRES; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0642345882     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/mge.2003.308     Document Type: Article

References (36)

1. American Gastroenterological Association medical position statement: evaluation of dyspepsia. Gastroenterology 1998;114:579-81.
2. American Society for Gastrointestinal Endoscopy. Appropriate use of gastrointestinal endoscopy. Gastrointest Endosc 2000;52:831-7.
3. Kahn KL, Roth CP, Kosecoff J, Fink A, Brook RH, Chassin M, et al. Indications for selected medical and surgical procedures. A literature review and ratings of appropriateness. Diagnostic upper gastrointestinal endoscopy. Santa Monica, Calif.: Rand Corp. 1986. RAND publication no. R-3204/4-CWP/HF/HCFA/PMT/RWJ.
4. Axon ATR. Chronic dyspepsia: who needs endoscopy? Gastroenterology 1997;112:1376-80.
5. Silverstein MD, Peterson T, Talley NJ. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology 1996;110:72-83.
6. Fennerty MB. Empirical H2 blocker therapy or prompt endoscopy in the management of dyspepsia. Gastrointest Endosc 1995;41:529-30.
7. Colin-Jones DG. When should endoscopy (or radiology) be used in dyspepsia and peptic ulcer disease? Aliment Pharmacol Ther 1987;1(Suppl 1):548-55.
8. Malagelada JR. When and how to investigate the dyspeptic patient. Scand J Gastroenterol 1991;182(Suppl):70-4.
9. Rabeneck L. Managing dyspepsia: is prompt endoscopy the way to go? Gastroenterology 1995;108:1324-6.
10. Jones R. When is endoscopy appropriate in dyspepsia? Am J Gastroenterol 1993;88:981-2.
11. Johnsen R. Endoscopy: why and when. Scand J Prim Health Care 1990;8:187-8.
12. Fendrick AM, Chernew ME, Hirth RA, Bloom BS. Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med 1995;123:260-8.
13. Williams B, Luckas M, Ellingham JH, Dain A, Wicks AC. Do young patients with dyspepsia need investigation? Lancet 1988;II:1349-51.
14. Heikkinen M, Pikkarainen P, Takala H, Rasanen H, Julkunen R. Etiology of dyspepsia: four hundred unselected consecutive patients in general practice. Scand J Gastroenterol 1995;30:519-23.
15. Kagevi I, Lofstedt S, Persson LG. Endoscopic findings and diagnoses in unselected dyspeptic patients at a primary health care center. Scand J Gastroenterol 1989;24:145-50.
16. Talley NJ. Helicobacter pylori and non-ulcer dyspepsia. Scand J Gastroenterol Suppl 1996;31:19-22.
17. Talley NJ, Stanghellini V, Heading RC, Koch K, Malagelada JR, Tytgat GN. Functional gastrointestinal disorders. In: Drossman DA, Corazziari E, Thompson WG, Talley NJ, Whitehead WE, editors. Functional gastrointestinal disorders, Rome II. 2nd ed. McLean (VA): Degnon Associates; 2000.
18. Asante MA, Mendall M, Patel P, Ballam L, Northfield TC. A randomized trial of endoscopy vs no endoscopy in the management of seronegative Helicobacter pylori dyspepsia. Eur J Gastroenterol Hepatol 1998;10:983-9.
19. McColl KE. Should non-invasive Helicobacter pylori testing replace endoscopy in investigation of dyspepsia? Helicobacter 2000;5:511-5.
20. McColl KE. Review article: tackling the "dyspeptic problem." Aliment Pharmacol Ther 2001;15:10-13.
21. Asante MA, Lord J, Mendall M, Northfield TC. Endoscopy for Helicobacter pylori sero-negative young dyspeptic patients: an economic evaluation based on a randomized trial. Eur J Gastroenterol Hepatol 1999;11:851-6.
22. Ebell MH, Warbasse L, Brenner C. Evaluation of the dyspeptic patient: a cost utility study. J Fam Pract 1997;44:545-55.
23. Health and Public Policy Committee ACP. Endoscopy in the evaluation of dyspepsia. Ann Intern Med 1985;102:266-9.
24. Hession PT, Malagelada JR. Review article: the initial management of uninvestigated dyspepsia in younger patients: the value of symptom-guided strategies should be reconsidered. Aliment Pharmacol Ther 2000;14:379-88.
25. Fass R, Ofman JJ. Gastroesophageal reflux diseas: should we adopt a new conceptual framework? Am J Gastroenterol 1997;8:1901-9.
26. Ofman JJ, Rabeneck L. The effectiveness of endoscopy in the management of dyspepsia: a qualitative systematic review. Am J Med 1999;106:335-46.
27. Sandler RS. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology 1990;99:409-15.
28. Agreus L, Svardsudd K, Nyren O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995;109:671-80.
29. Whorwell PJ, McCallum M, Creed FH, Roberts CT. Non-colonic features of irritable bowel syndrome. Gut 1986;27:37-40.
30. Allescher HD, Adler G, Hartung J, Manns MP, Riemann JF, Wienbeck M, et al. Prospective epidemiologic study of epigastric discomfort (PRESTO). Ground work and preliminary results. Dtsch Med Wochenschr 1999;124:443-50.
31. Talley NJ, Weaver AL, Zinsmeister AR. Smoking, alcohol, and non-steroidal anti-inflammatory drugs in outpatients with functional dyspepsia and among dyspepsia subgroups. Am J Gastroenterol 1994;89:524-8.
32. Wolfe MM, Lichtenstein R, Singh G. Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs. N Engl J Med 1999;340:1888-99.
33. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of non-steroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 1991;115:787-96.
34. Lai KC, Lam SK, Chu KM, Wong BCY, Hui WM, Hu WHC, et al. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 2002;346:2033-8.
35. Graham DY, Agrawal NM, Campbell DR, Haber MM, Collis C, Lukasik NL, et al. Ulcer prevention in long-term users of non-steroidal anti-inflammatory drugs. Arch Intern Med 2002;162:169-75.
36. Yeomans ND, Tulassay Z, Juhasz L, Racz I, Howand JM, van Rensburg CJ, et al. A comparison of omeprazole with ranitidine for ulcers associated with non-steroidal anti-inflammatory drugs. N Engl J Med 1998;338:719-26.